PCSK9 Inhibitors: A New Era in Lipid-Lowering Treatment?

Ann Intern Med. 2015 Jul 7;163(1):64-5. doi: 10.7326/M15-0920.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Anticholesteremic Agents / therapeutic use*
  • Female
  • Humans
  • Hypercholesterolemia / drug therapy*
  • Male
  • Proprotein Convertases / immunology*
  • Serine Endopeptidases / immunology*

Substances

  • Antibodies, Monoclonal
  • Anticholesteremic Agents
  • Proprotein Convertases
  • Serine Endopeptidases